Frequent Hemodialysis Network - West Coast Consortium
频繁血液透析网络 - 西海岸联盟
基本信息
- 批准号:7523299
- 负责人:
- 金额:$ 80万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdherenceAdultAnemiaBlood VesselsCaliforniaCardiacCardiovascular systemChildClinicalClinical Trials DesignCommitCommunitiesCoronary arteryDialysis procedureDietary intakeDiseaseDoseEnd stage renal failureEnrollmentEvaluationEventFrequenciesFundingGoalsHealthHemodialysisHemoglobinHospitalizationHospitalsHypertensionHypotensionIndustryInflammationIntakeKidneyLeftLeft Ventricular MassLegLength of StayMaintenanceMedical centerMetabolismMineralsMorbidity - disease rateMovementNumbersNutritional statusOutcomeOxidative StressPartner in relationshipPersonal SatisfactionPhysical DialysisPhysical FunctionPhysical activityPhysiologic pulsePilot ProjectsPrincipal InvestigatorProtein-Energy MalnutritionPublishingPulse PressurePulse takingQuality of lifeRandomizedRandomized Clinical TrialsRateReportingResearch PersonnelResidual stateRestless Legs SyndromeRiskSF-36SafetySample SizeSiteSleepStressStructureTestingThrombosisUniversitiesUremiaVentricularWeekWorkattenuationbaseburden of illnesscalcificationcognitive functionexperiencehealth related quality of lifeimprovedmortalityprogramsracial and ethnicsocioeconomicsvolume hypertension
项目摘要
DESCRIPTION (provided by applicant):
The Frequent Hemodialysis Network (FHN) Study is a randomized clinical trial designed to test hypotheses related to the feasibility, safety, and efficacy of frequent (6x per week) vs. conventional (3x per week) hemodialysis. The recently completed NIDDK-funded MEMO Study demonstrated that survival and many other outcomes were not appreciably influenced by significant increases in equilibrated Kt/Vurea, a parameter of dialysis dose, when hemodialysis was given thrice weekly. Clinical experience and published anecdotal reports suggest that more frequent dialysis may result in reduced frequency and duration of hospitalization, improved control of volume overload, hypertension and anemia, correction of disorders of mineral metabolism, and enhanced quality of life. Given the high mortality rates and significant morbidity associated with end-stage renal disease, a rigorous evaluation of alternative dialysis strategies is warranted. The Investigators have constructed a consortium of University- and community-based nephrologists and dialysis units throughout the state of California - the California Coordinating Clinical Center (CCC). We serve urban and suburban communities with extensive racial, ethnic and socioeconomic diversity. We intend on enrolling 125 subjects (adults and children) as requested by the RFA. Subject recruitment, retention and adherence have been excellent; plans are in place to augment recruitment at existing sites by approaching additional local dialysis facilities and to expand recruitment to VA medical centers affiliated with participating universities. The sample size will not be sufficient to demonstrate a difference in survival among groups. Safety and clinical events (e.g., hospitalization) will continue to be carefully tracked. With continued enrollment and randomization, the study should have sufficient power to detect clinically meaningful differences in the co-primary outcomes (the composite of mortality and change in left ventricular mass; and the composite of mortality and change in the Physical Health Composite of the SF-36). The study should also have sufficient power to detect clinically meaningful differences in other secondary outcomes. Dr. Chertow and his colleages have assembled a talented group of investigators and coordinators. The consortium has worked effectively with multiple industry partners. We are collectively committed to working cooperatively and constructively with the other CCC and DCC to reach all FHN study goals.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GLENN MATTHEW CHERTOW其他文献
GLENN MATTHEW CHERTOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GLENN MATTHEW CHERTOW', 18)}}的其他基金
Mentoring Patient-Oriented Clinical Investigators in Nephrology
指导肾脏病学领域以患者为中心的临床研究人员
- 批准号:
9756371 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Mentoring Patient-Oriented Clinical Investigators in Nephrology
指导肾脏病学领域以患者为中心的临床研究人员
- 批准号:
10260399 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Mentoring Patient-Oriented Clinical Investigators in Nephrology
指导肾脏病学领域以患者为中心的临床研究人员
- 批准号:
10442626 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Mentoring Patient-Oriented Clinical Investigators in Nephrology
指导肾脏病学领域以患者为中心的临床研究人员
- 批准号:
10001452 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Mentoring Patient-Oriented Clinical Investigators in Nephrology
指导肾脏病学领域以患者为中心的临床研究人员
- 批准号:
8075596 - 财政年份:2010
- 资助金额:
$ 80万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 80万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 80万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 80万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 80万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 80万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 80万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 80万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 80万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 80万 - 项目类别: